(ICPT) - Earnings & Price History

ICPT: - 59.51, $1.52B, -1.72 (-2.81%)

Sector: Healthcare - Industry: Biotechnology

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid, a bile acid analog, that completed Phase III clinical trials for the treatment of primary biliary cholangitis and Phase II clinical trials for the treatment of nonalcoholic fatty liver disease; and is in Phase III clinical trials for the treatment of nonalcoholic steatohepatitis, Phase II clinical trials for the treatments of primary sclerosing cholangitis, and Phase II clinical trial for the treatment of biliary atresia. The company is also developing INT-767, an orally administered dual FXR and TGR5 agonist, which is in Phase I clinical trial for the treatment of fibrosis; and INT-777, an orally administered TGR5 agonist that is in preclinical stage for the treatment

Past ICPT reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-23BMO-3.74115.93122.79123111.61230.17%-5.75%-5.59%1.43M
2016-11-03BMO-3.8298.2117.5512098.2120.12.08%-18.17%-16.46%1.76M
2016-08-04BMO-3.7163.21172.59170.77160.4173.58-1.05%▲-4.43%-5.43%622.30K
2016-05-05AMC-3.6133.34136.99135.19132.51139.13-1.31%-1.37%-2.66%408.87K
2016-02-23BMO-3.15119.29121.76118.05117.24124-3.05%1.05%-2.03%609.31K
2015-11-09BMO-2.74192.29176.7178.29174.01194.650.90%7.85%8.82%596.22K
2015-08-05AMC249.55260.13258248.05259.89-0.82%▲-3.28%-4.07%53.43K
2015-03-02BMO-1.67225.54221.37216.94213231.35-2.00%3.96%1.88%503.82K
2014-11-07BMOIntercept Pharm-1.1-1.69172.59246.98199.03162.06208.9-19.41%-13.28%-30.12%4.04M
2014-08-11AMCIntercept Pharm-1.11.51276.52237.18345.62274349.0845.72%▲-19.99%16.59%6.08M
2014-05-07AMCIntercept Pharm-0.76-1.59231.24254.48245228.05250-3.73%-5.62%-9.13%524.30K
2014-03-14AMCIntercept Pharm-0.6-0.72407.16462.26463.91386478.470.36%-12.23%-11.92%2.20M
2013-11-25Intercept Pharm-0.57-0.6451.9650.6650.950.952.150.47%2.08%2.57%91.00K
2013-08-13Intercept Pharm-0.52-0.7946.1946.0846.344646.640.56%▲-0.32%0.24%41.70K
2013-03-18AMC-0.34

Login | Register
Tuesday Sep 26, 2017   EST
Enter a Ticker:

Economic Calendar

Redbook 8:55 AM ET S&P Corelogic Case-Shiller HPI 9:00 AM ET Charles Evans Speaks 9:30 AM ET Loretta Mester Speaks 9:30 AM ET New Home Sales 10:00 AM ET Consumer Confidence 10:00 AM ET Richmond Fed Manufacturing Index 10:00 AM ET State Street Investor Confidence Index 10:00 AM ET Lael Brainard Speaks 10:30 AM ET 4-Week Bill Auction 11:30 AM ET Raphael Bostic Speaks 12:30 PM ET 2-Yr Note Auction 1:00 PM ET 

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY249.440.510.20%25,763,963

Upgrades/Downgrades